Blog

Beta blockers may improve response to immunotherapy in metastatic melanoma – Healio

Beta blockers may improve response to immunotherapy in metastatic melanoma
Healio
Patients with metastatic melanoma who underwent treatment with immunotherapy derived a benefit when they also received beta blockers, according to study results. Todd Schell, PhD, professor of microbiology and immunology at Penn State College of

2018-02-23 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.